ABSTRACTConcurrent with the global escalation of the AIDS pandemic, cryptococcal infections are increasing and are of significant medical importance. Furthermore,Cryptococcus neoformanshas become a primary human pathogen, causing infection in seemingly healthy individuals. Although numerous studies have elucidated the virulence properties ofC. neoformans, less is understood regarding lung host immune factors during early stages of fungal infection. Based on our previous studies documenting that pulmonary surfactant protein D (SP-D) protectsC. neoformanscells against macrophage-mediated defense mechanismsin vitro(S. Geunes-Boyer et al., Infect. Immun. 77:2783–2794, 2009), we postulated that SP-D would facilitate fungal infectionin vivo. To test this hypothesis, we examined the role of SP-D in response toC. neoformansusing SP-D−/−mice. Here, we demonstrate that mice lacking SP-D were partially protected duringC. neoformansinfection; they displayed a longer mean time to death and decreased fungal burden at several time points postinfection than wild-type mice. This effect was reversed by the administration of exogenous SP-D. Furthermore, we show that SP-D bound to the surface of the yeast cells and protected the pathogenic microbes against macrophage-mediated defense mechanisms and hydrogen peroxide (H2O2)-induced oxidative stressin vitroandin vivo. These findings indicate thatC. neoformansis capable of coopting host SP-D to increase host susceptibility to the yeast. This study establishes a new paradigm for the role played by SP-D during host responses toC. neoformansand consequently imparts insight into potential future preventive and/or treatment strategies for cryptococcosis.